Report Detail

Request for Sample of this report

Other Global mRNA Cancer Vaccines and Therapeutics Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4656444
    • |
  • 19 March, 2026
    • |
  • Global
    • |
  • 83 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global mRNA Cancer Vaccines and Therapeutics market size was valued at US$ 8471 million in 2025 and is forecast to a readjusted size of US$ 11780 million by 2032 with a CAGR of 4.9% during review period.
mRNA cancer vaccines and therapeutics are a novel class of tumor immunotherapy products based on messenger RNA (mRNA) technology. This approach involves designing and delivering mRNA molecules encoding tumor-associated antigens, enabling the patient’s immune system to recognize and attack cancer cells, thereby achieving precise and effective anti-cancer responses. Compared to traditional cancer treatments, mRNA technology offers advantages such as shorter development cycles, flexible manufacturing, and strong potential for personalized customization, significantly enhancing treatment safety and efficacy. With rapid advances in biopharmaceuticals and gene editing technologies, mRNA cancer vaccines and therapeutics have emerged as a critical breakthrough in tumor immunotherapy, ushering cancer treatment into the era of precision immunotherapy.
The rising global cancer incidence and mortality rates drive urgent demand for innovative therapies to improve treatment outcomes and patient survival. Leading biopharmaceutical companies’ annual reports highlight sustained investments in mRNA technology platforms, accelerating R&D of cancer vaccines and therapeutics while ensuring safety and efficacy. Government support through policies and funding fosters faster clinical trials and market access. The flexibility and personalization capabilities of mRNA technology meet diverse needs across cancer types and patient populations, showing great potential especially in hard-to-treat and recurrent cancers. Global aging populations and the spread of precision medicine concepts further fuel rapid market growth.
Despite vast market potential, challenges remain. Complex and costly R&D processes with extended validation periods increase development risks. Regulatory environments are evolving, with divergent approval standards and pathways across countries complicating international commercialization. High R&D and manufacturing costs contribute to expensive therapies, limiting patient access in some regions. Intense competition and complex interplay between traditional and emerging immunotherapies require companies to continuously innovate to sustain competitive advantage.
Downstream demand for mRNA cancer vaccines and therapeutics is moving toward diversification and precision. Major comprehensive hospitals and oncology centers prioritize efficacy, safety, and personalized treatment regimens. Patient and market demand for innovative and effective therapies drives growth in personalized mRNA vaccine customization services, fostering a precision medicine ecosystem. Advances in companion diagnostics and data-driven decision-making enable more precise patient stratification and improved clinical outcomes. Accelerated integration of biotech and information technology will expand mRNA cancer therapies to broader cancer types and more complex treatment scenarios.
This report is a detailed and comprehensive analysis for global mRNA Cancer Vaccines and Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts, in consumption value ($ Million), 2021-2032
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global mRNA Cancer Vaccines and Therapeutics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Cancer Vaccines and Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Cancer Vaccines and Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna Therapeutics, Pfizer, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
mRNA Cancer Vaccines and Therapeutics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Market segment by Application
Infectious Disease
Cancer
Others
Market segment by players, this report covers
Moderna Therapeutics
Pfizer
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe mRNA Cancer Vaccines and Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Cancer Vaccines and Therapeutics, with revenue, gross margin, and global market share of mRNA Cancer Vaccines and Therapeutics from 2021 to 2026.
Chapter 3, the mRNA Cancer Vaccines and Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and mRNA Cancer Vaccines and Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Cancer Vaccines and Therapeutics.
Chapter 13, to describe mRNA Cancer Vaccines and Therapeutics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of mRNA Cancer Vaccines and Therapeutics by Type
    • 1.3.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type in 2025
    • 1.3.3 Adeno Carcinomas
    • 1.3.4 Mucinous Carcinomas
    • 1.3.5 Adenosquamous Carcinomas
  • 1.4 Global mRNA Cancer Vaccines and Therapeutics Market by Application
    • 1.4.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Infectious Disease
    • 1.4.3 Cancer
    • 1.4.4 Others
  • 1.5 Global mRNA Cancer Vaccines and Therapeutics Market Size & Forecast
  • 1.6 Global mRNA Cancer Vaccines and Therapeutics Market Size and Forecast by Region
    • 1.6.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region, (2021-2032)
    • 1.6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2021-2032)
    • 1.6.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2021-2032)
    • 1.6.6 South America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Moderna Therapeutics
    • 2.1.1 Moderna Therapeutics Details
    • 2.1.2 Moderna Therapeutics Major Business
    • 2.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
    • 2.1.4 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Moderna Therapeutics Recent Developments and Future Plans
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer mRNA Cancer Vaccines and Therapeutics Product and Solutions
    • 2.2.4 Pfizer mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Pfizer Recent Developments and Future Plans
  • 2.3 Translate Bio
    • 2.3.1 Translate Bio Details
    • 2.3.2 Translate Bio Major Business
    • 2.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Solutions
    • 2.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Translate Bio Recent Developments and Future Plans
  • 2.4 BioNTech
    • 2.4.1 BioNTech Details
    • 2.4.2 BioNTech Major Business
    • 2.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Product and Solutions
    • 2.4.4 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 BioNTech Recent Developments and Future Plans
  • 2.5 Sangamo Therapeutics
    • 2.5.1 Sangamo Therapeutics Details
    • 2.5.2 Sangamo Therapeutics Major Business
    • 2.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
    • 2.5.4 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sangamo Therapeutics Recent Developments and Future Plans
  • 2.6 Argos Therapeutics
    • 2.6.1 Argos Therapeutics Details
    • 2.6.2 Argos Therapeutics Major Business
    • 2.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
    • 2.6.4 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Argos Therapeutics Recent Developments and Future Plans
  • 2.7 In-Cell-Art
    • 2.7.1 In-Cell-Art Details
    • 2.7.2 In-Cell-Art Major Business
    • 2.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Solutions
    • 2.7.4 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 In-Cell-Art Recent Developments and Future Plans
  • 2.8 eTheRNA
    • 2.8.1 eTheRNA Details
    • 2.8.2 eTheRNA Major Business
    • 2.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Solutions
    • 2.8.4 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 eTheRNA Recent Developments and Future Plans
  • 2.9 Ethris
    • 2.9.1 Ethris Details
    • 2.9.2 Ethris Major Business
    • 2.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Product and Solutions
    • 2.9.4 Ethris mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Ethris Recent Developments and Future Plans
  • 2.10 Tiba Biotechnology
    • 2.10.1 Tiba Biotechnology Details
    • 2.10.2 Tiba Biotechnology Major Business
    • 2.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Solutions
    • 2.10.4 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Tiba Biotechnology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of mRNA Cancer Vaccines and Therapeutics by Company Revenue
    • 3.2.2 Top 3 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2025
    • 3.2.3 Top 6 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2025
  • 3.3 mRNA Cancer Vaccines and Therapeutics Market: Overall Company Footprint Analysis
    • 3.3.1 mRNA Cancer Vaccines and Therapeutics Market: Region Footprint
    • 3.3.2 mRNA Cancer Vaccines and Therapeutics Market: Company Product Type Footprint
    • 3.3.3 mRNA Cancer Vaccines and Therapeutics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2021-2032)
  • 6.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2021-2032)
  • 6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
    • 6.3.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2021-2032)
    • 6.3.2 United States mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 6.3.3 Canada mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2021-2032)
  • 7.2 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2021-2032)
  • 7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
    • 7.3.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2021-2032)
    • 7.3.2 Germany mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 7.3.3 France mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 7.3.5 Russia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 7.3.6 Italy mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region
    • 8.3.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2021-2032)
    • 8.3.2 China mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 8.3.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 8.3.5 India mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 8.3.7 Australia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2021-2032)
  • 9.2 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2021-2032)
  • 9.3 South America mRNA Cancer Vaccines and Therapeutics Market Size by Country
    • 9.3.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
    • 10.3.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)
    • 10.3.4 UAE mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 mRNA Cancer Vaccines and Therapeutics Market Drivers
  • 11.2 mRNA Cancer Vaccines and Therapeutics Market Restraints
  • 11.3 mRNA Cancer Vaccines and Therapeutics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 mRNA Cancer Vaccines and Therapeutics Industry Chain
  • 12.2 mRNA Cancer Vaccines and Therapeutics Upstream Analysis
  • 12.3 mRNA Cancer Vaccines and Therapeutics Midstream Analysis
  • 12.4 mRNA Cancer Vaccines and Therapeutics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on mRNA Cancer Vaccines and Therapeutics. Industry analysis & Market Report on mRNA Cancer Vaccines and Therapeutics is a syndicated market report, published as Global mRNA Cancer Vaccines and Therapeutics Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of mRNA Cancer Vaccines and Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo